In an attempt to establish a relationship between food intake and fear/anxiety-related behaviours, the goal of this study was to investigate the effect of bilateral injections of GABAA (Muscimol, MUS, doses 25 and 50 ng/ side) and GABAB (Baclofen, BAC, doses 32 and 64 ng/side) receptor agonists in the nucleus accumbens shell (AcbSh) on the level of fear/anxiety-like and feeding behaviours in 24 h food-deprived rats. The antagonists of GABAA (Bicuculline, BIC, doses 75 and 150 ng/side) and GABAB (Saclofen, SAC, doses 1.5 and 3 μg/side) were also tested. The results indicated that the total number of risk assessment behaviour decreased after the injection of both doses of GABAA agonist (MUS) into the AcbSh of 24 h food-deprived rats exposed to elevated plus maze. Similar results were obtained after treatment with both doses of GABAB (BAC) agonist in the AcbSh. These data indicated that the activation of both GABAA and GABAB receptors within the AcbSh caused anxiolysis in 24 h food-deprived rats. In addition, feeding behaviour (food intake, feeding latency and feeding duration) remained unchanged after treatment with both GABA agonists. In contrast, both food intake and feeding duration decreased after injections of both doses of BIC (GABAA antagonist), while the feeding latency remained unchanged after treatment with both GABA antagonists in the AcbSh of 24 h food-deprived rats. The treatment with SAC (GABAB antagonist) did not affect feeding behaviour. Collectively, these data suggest that emotional changes evoked by pharmacological manipulation of the GABA neurotransmission in the AcbSh are not linked with changes in food intake.
Introduction
The nucleus accumbens (Acb) is a structure located in the basal forebrain and is a major component of the ventral striatum (Zahm, 2000) . It consists of two sub-regions, core and shell, which differ in both anatomic organisation and functional properties (Kelley, 2004; Voorn et al., 2004; Zahm, 2000; Zahm and Brog, 1992; Zahm and Heimer, 1993) . The manipulation of multiple neurotransmitter systems within the Acb has implicated this nucleus in the control of feeding behaviour. The stimulation of both GABAA and GABAB stimulate food intake in free-feeding rats as well as AMPA-type glutamate receptor blockade in the nucleus accumbens shell (AcbSh) (Kelley and Swanson, 1997; Maldonado-Irizarry et al., 1995; Kelley, 1997, 1999) . In contrast, these GABA antagonists administered into AcbSh decreased food intake in 24 h food-deprived rats (Kandov et al., 2006) . These effects on feeding are not observed with similar injections into the nucleus accumbens core, lateral shell, or other parts of the striatum (Basso and Kelley, 1999; Kelley and Swanson, 1997) , supporting the hypothesis of a functional division among the striatum.
Opioid-agonist injections into the AcbSh have been shown to increased food intake, whereas opioid antagonists reduce consumption (Kelley et al., 1996; Peciña and Berridge, 2000) . Furthermore, the activation of different serotonin receptor subtypes (5-HT 1/7 , 6,4 in satiated rats by Pratt et al., 2009; 5-HT 4 in satiated and deprived mice by Jean et al., 2007) within the medial Acb also influences feeding behaviour in rodents. Neuropeptides were also identified in the AcbSh circuits controlling feeding behaviour. It has been shown that the activation of the AcbSh endocannabinoid CB1 or melanin-concentrating hormone receptors resulted in a hyperphagic effect (Georgescu et al., 2005; Guesdon et al., 2009; Kirkham et al., 2002; Soria-Gómez et al., 2007) . Therefore these studies suggest a strong relation between food intake and AcbSh circuitry activation.
Although, traditionally, the AcbSh has not been considered a region involved in anxiety regulation, there is substantial evidence that implicates it with defensive and anxiety-like behaviours (Avena et al., 2008; Martinez et al., 2002; Pliakas et al., 2001; Berridge, 2001, 2003; Sturm et al., 2003) . This region receives connections of glutamatergic neurons from limbic areas such as the prefrontal cortex, ventral hippocampus and basolateral amygdale. It also receives connections from other brain areas such as the lateral septum, amygdala, lateral hypothalamus area ventral tegmental, and dorsal raphe nucleus and locus coeruleus (Brog et al., 1993) , which were all associated with stressful stimuli or anxiety (Aston-Jones and Harris, 2004; Charney and Deutch, 1996; Picciotto et al., 2002) . The fact that the AcbSh is considered an interface between limbic and motor systems (Mogenson et al., 1980) may explain its potential role in anxiety-like behaviour.
We have been investigating the participation of GABA and glutamate neurotransmission within AcbSh in an attempt to establish a relationship between food intake and fear/anxiety-related behaviours, as patients with feeding disorders frequently exhibit symptoms of anxiety and there is a high comorbidity between eating disorders and anxiety disorders (Fornari et al., 1992; Mitchell et al., 1991) . Previous studies conducted in our laboratory showed that the activation of both GABAA and GABAB receptors in the AcbSh decreased the level of fear/ anxiety and increased food intake in free-feeding animals, without a positive correlation between both behaviours (Lopes et al., 2007) .
Moreover, treatments with AMPA receptor antagonists induced anxiolytic-like effects without affecting feeding behaviour (Da Cunha et al., 2008a , 2008b . In the present work, we extend our studies on the relationship between food intake and fear/anxiety-related behaviours, examining the effects of the injection of GABA agonists and antagonists into the AcbSh on fear/anxiety-like behaviour tested in the elevated plus-maze (EPM) followed by immediate recording of feeding behaviour in the 24 h food-deprived rats since abstinence or spontaneously emergent withdrawal is a more realistic condition of animals in the wild or the human condition during famine or severe dieting, and, in addition, anxiogenic-like behaviour has been demonstrated in food restriction condition (Inoue et al., 2004) .
Materials and methods

Animals
Adult male Wistar rats weighing approximately 290 g were supplied by the animal breeding division of the Federal University of Santa Catarina (UFSC). The animals were housed in cages by groups of 5 and submitted to a 7-day period of adaptation with food (CR-1, Nuvilab) and water ad libitum with a light/dark cycle of 12 h (lights on 6 am). The animals were only handled for weighing, drug administration, and cage cleaning. All the experimental procedures described below were approved by the University's Committee for Ethics in Animal Research (CEUA-UFSC, protocol # PP00283/CEUA).
Stereotaxic surgery
At least 7 days before the experiments, each animal was anaesthetised by the intraperitoneal (i.p.) route with a ketamine hydrochloride (87 mg kg − 1 ) and xylazine (13 mg kg − 1 ) mixture. Bilateral stainless steel guide cannulae (30 G) were implanted using stereotaxic techniques. The guide cannulae were aimed at sites located 2 mm dorsal to medial AcbSh according to coordinates derived from the Paxinos and Watson atlas (2007) . The cannulae were anchored in the skull with dental cement and the whole implant stabilised with jeweller screws and more dental cement. A removable stylet was introduced to keep the cannula free from blockages until the day of the experiment.
Drug injections
Injections were made through inner cannula (30 G) extending 2 mm beyond the ventral tip of the guide cannula connected by polyethylene tubing to a Hamilton microsyringe (1 μl) fitted to an injection pump. The injected volume was 0.2 μl of agonist or 0.5 μl of antagonist administered bilaterally over a period of 60 s and a further 60 s was allowed for the solution to diffuse from the cannula. This relatively high injection volume was necessary because of limited solubility of the antagonists (see by Kandov et al., 2006; Stratford and Kelley, 1997) . The animals received a bilateral injection of muscimol (MUS, GABAA receptor agonist, doses 25 and 50 ng/side, equivalent to 128 and 256 pmol doses used in our previous study, Lopes et al., 2007) , baclofen (BAC, GABAB receptor agonist, doses 32 and 64 ng/ side, equivalent to 128 pmol and 256 pmol doses used in our previous study, Lopes et al., 2007) , bicuculline (BIC, GABAA receptor antagonist, doses 75 and 150 ng/side, doses derived from behaviour studies carried out by Kandov et al., 2006) or saclofen (SAC, GABAB receptor antagonist, doses 1.5 and 3 μg/side, doses derived from behaviour studies carried out by Kandov et al., 2006) . All drugs were purchased from Aldrich-Sigma Chemical Company (St. Louis, USA) and freshly dissolved in 0.9% sterile saline before the experiments.
Experimental procedures
During a week after surgery the rats were housed individually with free access to food and water. After this period, the animals were 24 h food-deprived, but continued to have free access to water. Each animal received only one drug-treatment to evaluate the effects of GABA agonists and antagonist receptor injections into the AcbSh on anxietylike, ingestive and non-ingestive behaviours. After the injection, each animal was placed on the central square of the elevated plus-maze (EPM) facing an enclosed arm and was allowed to explore a maze for 5 min. In sequence, the rats were transferred to the feeding recording chamber to evaluate the ingestive and non-ingestive behaviours for 30 min. Each experimental session was recorded by a video camera in an adjacent room and subsequently transcribed through the Etholog 2.25 software (Ottoni, 2000) .
Anxiety-like behaviour
The elevated plus-maze (EPM) is one of the most used tests to measure the anxiety-like behaviour in animal models. It consists of two open and two closed arms of the same size (50 cm × 10 cm) arranged in the form of a cross 50 cm above the floor; the arms were connected by a central 10 cm × 10 cm area. The two open arms were surrounded by a short (1 cm) Plexiglas edge to keep the animals from falling while the closed arms have 40 cm high opaque glass walls, except for the entrance. Four 15 W fluorescent lights arranged across 100 cm above the maze were used as a source of illumination and provided different levels of lux incidence on the open and closed arms. The mean illumination level in the open arms and closed arms were 373 and 284 lx respectively, with an 89 lx gradient of illumination between the open and closed arms. To avoid odoriferous cues between animals, the maze was cleaned with wet (alcohol 20%, v/v) and dry cloths.
To evaluate the anxiety-like behaviour we used spatial-temporal variables: number of entries into either open or enclosed arms (arms entry and exit were defined when all four paws were into and or out of an arm), and the total number of entries. Exploratory behaviour on the open arms was expressed by the mean percentage of entries (%Open arm entries) and the time spent or percentage in the open, centre and enclosed arm (%Open, Centre and Enclosed arm time). The rat preference between the enclosed arms was evaluated through the mean percentage of either entries or time spent in the light enclosed arm. Additionally, ethologically derived measures were also evaluated as follows: the total number of risk assessment (stretched-attend postures-SAP: exploratory posture, into the open, enclosed and centre arms, in which the body is stretched forward then retracted to the original position without any forward movement); number of rearing (standing on their hind limbs); number of head-dipping (protruding the head over the edge of an open arm and scrutinising in the direction of the floor); and number of grooming (cleaning any part of the body surface with the tongue, teeth, and/ or forepaws).
Food intake behaviour
Immediately after the exposure to the EPM test, each animal was placed for 30 min in a feeding chamber containing standard rodent chow and tap water. After this period the amount of food and water consumed was measured. Throughout the experimental session, the ingestive and non-ingestive behaviours were recorded by a video camera perpendicularly located 60 cm above the chamber floor for subsequent detailed analysis through Etholog 2.25 software (Ottoni, 2000) . The feeding chamber was constructed with transparent glass (49 cm × 34 cm × 32 cm). The back and lateral walls, as well as the floor cage were coated with a black adhesive plastic paper. In order to facilitate behavioural recording, the front wall of the test cage had a mirror with the same dimensions arranged in a 45°angle in relation to the vertical plane. This mirror arrangement also prevented the animal from seeing its reflection in the mirror.
The following variables were evaluated: feeding latency; duration (amount of time the animal's mouth was either touching or chewing a food pellet); grooming duration (defined as paw strokes over the face or licking of the paws or body); locomotion duration (defined as front-to-back chamber crossings); rearing duration (defined as front paws raised from the chamber floor); risk assessment duration (see Section 2.4.1); and resting time (tucking head against chest without movement for more than 5 s) (Rodgers et al., 1999) . All the experiments were carried out during the light phase of the cycle between 11:00 am and 3:00 pm.
Histological analysis
At the end of the experiments, the animals were deeply anaesthetised and transcardially perfused with 0.9% saline followed by 10% formalin. The brains were removed and subsequently cut (vibratome) in the transverse plane (100 μm). Sections were stained with cresyl violet and the cannula loci were examined and documented through a camera lucida attached to a microscope. Cannula placements were mapped onto the corresponding areas of the Atlas of The Rat Brain Fig. 1 . Photomicrograph and schematic representation of bilateral cannula placements in the AcbSh in 75 rats receiving injection of vehicle (saline n = 9, △), GABA agonist, MUS (25 ng/side, n = 7, ■; 50 ng/side, n = 7, ) and BAC (32 ng/side, n = 7, ▲; 64 ng/side, n = 6, ), or vehicle (saline n = 9, ), GABA antagonist, BIC (75 ng/side, n = 7, □; 150 ng/ side, n = 7, ○) and SAC (1.5 μg/side, n = 8, •; 3 μg/side, n = 8, ). The coronal sections (scale bar = 100 μm) of the rat brain according to the atlas of Paxinos and Watson (2007) illustrating the distribution of the injection sites. All cannulae tips were localised within the AcbSh, 1.20 to 1.92 mm, anterior to the bregma structure. AcbC: nucleus accumbens core; AcbSh: nucleus accumbens shell; aca: anterior commissure, anterior part. (Paxinos and Watson, 2007) . Data from rats with misplaced cannula in the AcbSh were not included in the analyses.
Statistical analysis
Separate one-way ANOVA tests were used to analyse the effects of treatment with GABA agonists and GABA antagonists in the AcbSh on anxiety-like, ingestive and non-ingestive behaviours. When appropriate, the ANOVA tests were followed by a post-hoc Duncan's test for multiple comparisons. The alpha level was adjusted using the Bonferroni correction for p b 0.0125 as we only considered the effective (4) comparisons made in our experiments; the results obtained after each dose of GABAA or GABAB agonist injected into the accumbens shell vs. the control group (1-saline vs. MUS 25; 2-saline vs. MUS 50; 3-saline vs. BAC 32; 4-saline vs. BAC 64). The same statistical procedure was applied to the data obtained after each dose of GABAA or GABAB antagonists.
Results
Anxiety-like behaviour after treatment with GABA agonists and antagonists in the AcbSh
Histological analysis indicated that 75 points of injection were within the AcbSh. Fig. 1 shows sequential coronal sections of the injection sites within the AcbSh.
The one-way ANOVA revealed that only total number risk assessment behaviour evaluated in EPM was significantly affected by treatment with GABA agonists [F(4,31) = 4.34; p = 0,0066]. The total number of risk assessment behaviour decreased after the injection of both doses of GABAA agonist (MUS) into the AcbSh of 24 h fooddeprived rats. Similar results were obtained after treatment with both doses of GABAB (BAC) agonist in the AcbSh. The other ethological behaviours and spatial-temporal parameters remained unchanged after bilateral injection of both GABAA and GABAB agonists into the AcbSh (Table 1 ). The one-way ANOVA indicated that both spatial-temporal parameters (number of entries into either open or enclosed arms; total number of entries; % open arm entries and the time spent or percentage into the open, centre and enclosed arm) and ethological behaviours (total number of risk assessment, number of head dipping, number of rearing, number of grooming) remained unchanged after treatment with both doses of GABAA (BIC) and GABAB (SAC) antagonists in the AcbSh of 24 h fooddeprived rats (Table 2) .
Ingestive behaviour after treatment with GABA agonists and antagonists in the AcbSh
Feeding behaviour (food intake, feeding latency and feeding duration) was not affected by bilateral injections of either GABA agonists into AcbSh of 24 h food-deprived rats ( Fig. 2A) . The one-way ANOVA showed that the other non-ingestive behaviours evaluated during feeding register (locomotion, resting, risk assessment, rearing Table 1 Effects of the bilateral injections of saline, GABAA (MUS) or GABAB (BAC) into the AcbSh of 24 h food-deprived rats on spatial-temporal and ethological variables, during 5 min of exposure to the elevated plus-maze.
Variables
Saline (n = 9) MUS 25 (n = 7) MUS 50 (n = 7) BAC 32 (n = 7) BAC 64 (n = 6) ANOVA (main effects)
Open entries 5 ± 0.5 3 ± 1 4 ± 1 2 ± 0.7 5 ± 0.9 F(4.31) = 2.35; NS Enclosed entries 6 ± 1 8 ± 1 6 ± 1 5 ± 0.9 8 ± 2 F(4.31) = 0.89; NS Total entries 11 ± 1 11 ± 2 10 ± 2 7 ± 1 13 ± 3 F(4. 5 ± 1 5 ± 1 4 ± 1 3 ± 1 5 ± 1 F(4.31) = 0.36; NS Rearing 7 ± 1 11 ± 4 10 ± 2 7 ± 2 11 ± 2 F(4.31) = 0.73; NS Grooming 3 ± 0 3 ± 0 2 ± 1 1 ± 0 2 ± 0 F(4.31) = 1.05; NS Each column represents the mean ± SEM. Numbers in parentheses refer to the number of animals examined for each treatment. ⁎ p b 0.0125 compared to the control group.
Table 2
Effects of the bilateral injections of saline, GABAA (BIC) or GABAB (SAC) into the AcbSh of 24 h food-deprived rats on spatial-temporal and ethological variables, during 5 min of exposure to the elevated plus-maze.
Variables Saline (n = 9) BIC 75 (n = 7) BIC 150 (n = 7) SAC 1.5 (n = 8) SAC 3.0 (n = 8) ANOVA (main effects)
Open entries 5 ± 0.6 5 ± 1 6 ± 1 5 ± 1 3 ± 1 F(4.34) = 0.63; NS Enclosed entries 7 ± 0.7 8 ± 1 8 ± 0.5 5 ± 1 5 ± 0.6 F(4.34) = 2.18; NS Total entries 12 ± 1 13 ± 1 14 ± 2 10 ± 2 9 ± 1 F(4.34) = 1. 11 ± 4 F(4.34) = 1.55; NS % Enclosed arms time 60 ± 4 62 ± 9 55 ± 6 36 ± 11 69 ± 11 F(4.34) = 1.95; NS Total risk assessment 1 ± 0.5 0.5 ± 0.2 0.1 ± 0.1 0.5 ± 0.3 1 ± 0.5 F(4,34) = 1.40; NS Head dipping 6 ± 1 6 ± 2 6 ± 2 7 ± 2 5 ± 1 F(4.34) = 0.27; NS Rearing 11 ± 1 9 ± 2 7 ± 2 8 ± 2 9 ± 3 F(4.34) = 1.19; NS Grooming 3 ± 0.5 2 ± 0.7 2 ± 0.5 2 ± 0.6 2 ± 0.3 F(4.34) = 0.44; NS Each column represents the mean ± SEM. Numbers in parentheses refer to the number of animals examined for each treatment.
and grooming) remained unchanged after treatment (Table 3) . Food intake [F(4,34) = 3.66; p = 0.01] and feeding duration [F(4,34) = 5.21; p = 0.002] were significantly affected by treatment with both GABA antagonist in the AcbSh of 24 h food-deprived rats. While both food intake and feeding duration decreased after injections of both doses of BIC (GABAA antagonist), the feeding latency remained unchanged after treatment with both GABA antagonists in the AcbSh of 24 h food-deprived rats (Fig. 2B ). The injection with both doses of GABAB antagonist into the AcbSh did not affect feeding behaviour. Non-ingestive behaviours remained unchanged after the treatment with both GABA antagonists (Table 4) .
Discussion
The risk assessment data indicate that the activation of both GABAA and GABAB receptors within the AcbSh caused anxiolysis in 24 h food-deprived rats since the injections of both doses of the GABAA receptor agonists (MUS) and GABAB receptor agonist (BAC) decreased the total number of risk assessment exhibition in 24 h food-deprived rats exposed to EPM. In our previous study the anxiolytic effect evoked by GABA A and GABA B agonists injected into the AcbSh of free-feeding rats was also indicated by a decrease in the total number of risk assessment. The spatial-temporal variables such as % open arms time and open arms entries showed a marginal significant trend to increase, reinforcing the anxiolytic effect induced by GABA agonists. In the present study, the spatial-temporal variables were not affected by treatment with GABAA or GABAB agonists.
The modest changes in the risk assessment could not provide compelling evidence that the rats are in a lesser anxious state following drug treatment. However, our present data added to our previous result (Lopes et al., 2007) strengthens the anxiolytic effect evoked by GABA agonist in the AcbSh. A possible reason for the lowest risk Fig. 2 . Effects of bilateral injections of saline, GABAA and GABAB agonists (A) or antagonists (B) into the AcbSh of the 24 h food-deprived rats on food intake, feeding latency and feeding duration, during 30 min exposure to the feeding chamber. Each column represents the mean ± S.E.M. *p b 0.0125 compared to the control group (one-way ANOVA followed by Duncan test for multiple comparisons and Bonferroni correction).
Table 3
Durations of non-ingestive behaviours (seconds) during 30 min in the feeding chamber test, under effects of bilateral injections of saline, GABAA (MUS) or GABAB (BAC) into the AcbSh in 24 h food-deprived rats. assessment number could be due to nutritional conditions. It has been reported that after acute and chronic food restriction, and after 10 days refeeding, rats increased open arm exploration compared to rats with continuous food access (Genn et al., 2003; Inoue et al., 2004) . This data indicate that food-deprived rats were less anxious than satiated rats. Our previous (Lopes et al., 2007) and present data confirm this emotional influence while the total number of risk assessment exhibited by 24 h food-deprived rats under control conditions was 1 ± 0.2, this number was 4 ± 0.6 for free-feeding rats (Lopes et al., 2007) . This difference was also statistically significant according to t test, t = 3.91 p = 0.000368. Furthermore, the anxiety state indicated by % open arms time under control conditions in the freefeeding was 12 ± 3 (n = 22) (Lopes et al., 2007) and in the 24 h food-deprived rats was 30 ± 4 (n = 18). This difference was also statistically significant according to t test, t = 3.61 p = 0.00087, and indicates that the 24 h food-deprived rats spent more time in the open arms than free-feeding rats. Therefore, our results confirm that the nutritional condition affects the anxiety expression. This anxiolytic-like effect associated to food deprivation could not be attributed to an increased motivation to forage for food or nonspecific behavioural activation as opposed to a genuine decrease in anxiety-like behaviour because rats did not exhibit increased closed arm entries, an index of locomotor/exploratory activity. Moreover, rats also continued to exhibit anxiolytic-like changes after refeeding, despite normalisation of energy balance (Inoue et al., 2004) . In addition, defensive burying behaviour, an active anxiogenic-like response unrelated to exploratory drive, was also reduced during food deprivation (Davis et al., 1981) .
The anxiolytic effects caused by GABAA (Crestani et al., 2002; Kash et al., 1999; Rudolph et al., 1999; Sasaki et al., 2002; Stork et al., 2003) and GABAB (Cryan et al., 2004; Cryan and Kaupmann, 2005; Davi and Rodgers, 1996; Jacobson et al., 2007; Mombereau et al., 2004a Mombereau et al., , 2004b receptors have been extensively described. In contrast, the fear/ anxiogenic effect associated to GABAA receptor activation was also documented. It has been shown that the injection of MUS into the AcbSh evoked a strong defensive burying or paw-treading behaviour (Reynolds and Berridge, 2001 ), a contradictory effect found when compared with our previous or present data. The anxiolytic effect mediated by both GABAA and GABAB receptor activation in both food-deprived rats (present results) and free-feeding rats (Lopes et al., 2007) could be attributed to different microinjection sites (rostral × caudal) within AcbSh. While the anxiolytic response was elicited by GABA agonists injected into the rostral sites within AcbSh (AP: +1.20 to +1.68 mm) in a previous work and (AP: +1.20 to +1.92 mm) in the present study, the defensive behaviour in rats was elicited by GABAA receptor agonist injected at more caudal sites (AP: +1.20 to +0.48 mm). However, a fear/anxiogenic response was also observed after GABAA injection in the rostral parts of AcbSh (Reynolds and Berridge, 2001 ). We do not have an explanation for the contrasting effect on animal emotionality after GABA agonist injection into the AcbSh, but our present data strengthen the anxiolytic effect evoked by both GABAA and GABAB receptor activation within AcbSh.
The present study also showed that feeding behaviour was not affected by bilateral injection of both GABA agonists, MUS and BAC, injected into the AcbSh of 24 h food-deprived rats. Similar results were observed after systemic injection of BAC in 22 h food deprived rats (Ebenezer, 1996; Ebenezer and Patel, 2011) . In contrast, in the free-feeding animals, treatment with both GABA agonists in the AcbSh had a hyperphagic response accompanied by an increase in feeding duration (Kelley et al., 2005; Lopes et al., 2007; Reynolds and Berridge, 2001; Soderpalm and Berridge, 2000; Kelley, 1997, 1999) . The lack of effects on feeding behaviour after injection of GABA agonists into AcbSh of food-deprived rats could be attributed to an intense occupation of GABAB (known to be localised on glutamate nerve terminals) or GABAA (located on output mediumspiny neurons) receptor due to intense stimulation of gabergic projections to AcbSh neurons that could result in elimination of AcbSh inhibitory influences on hypothalamic feeding-related circuitry, providing a hungry rat a prompt to start feeding (Kelley et al., 2005) .
In the present result we showed that the GABAA receptor blockade by injection of GABAA receptor antagonists into the AcbSh of 24 h food-deprived rats evoked decreased food intake accompanied by reduction in the feeding duration. This data suggest the presence of neural impulses mediated by GABAA receptors within AcbSh that elicit feeding motivation in hungry rats and reinforce our previous suggestion that in food deprived conditions the occupation of GABA receptors within AcbSh could be intense. The participation of GABAB receptors mediating feeding motivation cannot be excluded since injections of GABAB receptor antagonist into AcbSh of 24 h food-deprived rats also resulted in hypophagia (Kandov et al., 2006) . The reason for the lack of hypophagic effect after the GABAB receptor blockade within the AcbSh in the present study could be attributed to a lower recording time (30 min) than the one registered by Kandov et al. (2006) (from 30 min to 4 h). Furthermore, Patel and Ebenezer (2004) have shown that the intracerebroventricular (icv) administration of the GABAB receptor antagonist CGP 35348 decreased feeding in 22 h fasted rats, 15 min after injection. The rapid onset of the hypophagia evoked by GABAB receptor antagonist may have been due to an action at a site outside the nucleus accumbens, suggesting the involvement of other central areas in the mediation of GABAB effect on feeding motivation.
It has been proposed that both GABAA and GABAB antagonists are functionally involved in the maintenance, but not in the initiation of deprivation-induced food intake, since both GABA antagonists failed to affect food intake 30 min after the injection into the AcbSh (Kandov et al., 2006) . However, the blockade of GABAA receptor resulted in food intake decrease accompanied by a reduction in feeding duration, without affecting feeding latency. An alteration in feeding duration has also been observed after GABAA receptor activation in free-feeding rats within the AcbSh. Taken together, these data reinforce our previous suggestion that GABAA circuitry within AcbSh could interfere with signals arising from the digestory tract to control meal size (Heisler and Tecott, 2000; Inoue et al., 1994; Jean et al., 2007) .
We have reported that manipulations of both GABA and glutamate neurotransmission within the Acb influence feeding and fear/ anxiety-related behaviours without establishing functional relationships between the two factors. Treatment with AMPA receptor antagonists induced anxiolytic-like effects in the EPM and, as evaluated by the reduction of stretched-attend postures in the feeding test, without modifying feeding behaviour (Da Cunha et al., 2008a , 2008b . Bilateral injections of either GABAA or GABAB agonist receptors into the AcbSh induced an anxiolytic-like effect and increased food intake, but without positive correlations between the two parameters (Lopes et al., 2007) . In the present study we showed that, while the stimulation of GABAA and GABAB receptor agonists evoked an anxiolytic effect, feeding behaviour remained unchanged. Furthermore, while both GABAA and GABAB antagonists injected into the AcbSh did not affect the anxiety-like behaviours, both doses of GABAA antagonist caused a hypophagic response. Collectively, these data suggest that emotional changes evoked by pharmacological manipulation of the GABA neurotransmission in the AcbSh are not linked with changes in food intake.
